Vascular endothelial growth factor

November 15, 2011

Still No Iluvien

Alimera Sciences suffers set back with Iluvien. In a complete response letter to the company, the FDA did not approve the device for diabetic retinopathy citing concerns over safety.
December 6, 2011

Eylea As Good As Lucentis

The FDA approved Eylea as a new treatment for wet macular degeneration. Recent reports indicate the drug is similar to Lucentis after the initial year of treatment. Why is this bad news?